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Role of the Renin Angiotensin 
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Restriction in Female Fischer rats
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Amrita V. Pai3, Laura Batista Tavares Mesquita2, Hong Ji1, Deoclécio Chianca Jr2, 
Rodrigo Cunha Alvim de Menezes2 & Kathryn Sandberg1
Severe food restriction (FR) is associated with blood pressure (BP) and cardiovascular dysfunction. 
The renin-angiotensin system (RAS) regulates BP and its dysregulation contributes to impaired 
cardiovascular function. Female Fischer rats were maintained on a control (CT) or severe FR (40% of CT) 
diet for 14 days. In response to severe FR, BP allostasis was achieved by up-regulating circulating Ang-
[1–8] by 1.3-fold through increased angiotensin converting enzyme (ACE) activity and by increasing the 
expression of AT1Rs 1.7-fold in mesenteric vessels. Activation of the RAS countered the depressor effect 
of the severe plasma volume reduction (≥30%). The RAS, however, still underperformed as evidenced 
by reduced pressor responses to Ang-[1–8] even though AT1Rs were still responsive to the depressor 
effects of an AT1R antagonist. The aldosterone (ALDO) response was also inadequate as no changes 
in plasma ALDO were observed after the large fall in plasma volume. These findings have implications 
for individuals who have experienced a period(s) of severe FR (e.g., anorexia nervosa, dieters, natural 
disasters) and suggests increased activity of the RAS in order to achieve allostasis contributes to the 
cardiovascular dysfunction associated with inadequate food intake.
Severe food restriction (FR) causes abnormalities in the heart, vascular system and kidneys and includes hypo-
tension, bradycardia, mitral valve prolapse and a prolonged QT interval1,2. Other medical complications include 
edema, electrolyte disturbances (e.g., hypokalemia and hypophosphatemia), nephrolithiasis and kidney failure3. 
Severe FR can be self-imposed as a result of eating disorders like anorexia nervosa (AN)4 or in individuals who 
intentionally reduce their percent body fat for their occupation (e.g., models, athletes, dancers) or other reasons 
(e.g., dieters). Non-voluntary FR occurs in situations when people have inadequate access to food such as in war, 
natural disasters, periods of famine or low socio-economic conditions5,6. Severe FR can also occur in illnesses 
like cancer and AIDS due to inadequate food intake as a result of nausea or low palatability7,8. In these cases, the 
malnutrition as a result of the severe FR can independently add to the health complications of the disease.
We have shown that female Fischer rats maintained on a severe FR diet for 14 days (40% of a normal diet) 
developed malnutrition and shared numerous biochemical and physiological parameters found in humans after 
severe FR9. FR rats exhibited increased sensitivity to cardiopulmonary reflexes, the Bezold-Jarisch reflex, and 
α1-adrenoreceptor responses. We and others have also shown this model of FR leads to the development of car-
diovascular abnormalities including ventricular hypertrophy and hypotension9,10.
The renin-angiotensin system (RAS) plays a critical role in blood pressure (BP) homeostasis and fluid and 
electrolyte balance and is a central regulator of cardiovascular and renal function. The activity of the octapeptide 
hormone angiotensin II (Ang-[1–8]) is widely targeted clinically in the treatment of hypertension and numer-
ous cardiovascular and kidney diseases. In addition to its peripheral and central effects, Ang-[1–8] can act as 
a paracrine, autocrine, and intracrine hormone11,12. Ang-[1–8] exerts its vasoconstrictor effects by binding to 
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angiotensin type 1 receptors (AT1R) in resistance vessels. Ang-[1–8] also acts in the brain to influence responses 
that modulate BP including water intake and the sympathetic nervous system13. In addition, Ang-[1–8] directly 
increases sodium and water reabsorption in the kidney and stimulates ALDO release from the zona glomerulosa 
of the adrenal gland14.
Animal studies of low protein isocaloric diets15 and chronic undernutrition16 implicate Ang-[1–8] in the car-
diovascular dysfunction associated with these conditions. Ang-[1–8] dysfunction is also implicated in the cardi-
ovascular abnormalities associated with AN. Women with AN exhibited reduced BP responses to Ang-[1–8]17. 
To further understand the impact of FR on the regulation of the RAS in the female, we investigated the effect of a 
severe FR diet in the female Fischer rat on the major peptides, receptors and enzymes of the RAS as well as BP and 
HR responses to RAS peptides and an antagonist of the AT1R.
Results
Hemodynamic parameters and urine and plasma measurements. Before beginning the FR pro-
tocol, there was no difference in initial body weight (BW) between the CT (184 ± 2 g) and FR (183 ± 1 g) animal 
groups or in daily food intake. Over 2 weeks, the CT group slowly gained weight while BW in the FR group con-
tinued to fall; by day 14, BW in the FR rats was 80% of the CT group (Fig. 1A). Daily food intake in the FR group 
was 40% of the CT animals (Fig. 1B). Daily water intake remained similar throughout the study in the CT group 
whereas after 8 days on the FR diet, daily water intake was 30% less than CT animals (Fig. 1C).
Figure 1. Effect of FR on BW and food and water intake. Shown is daily BW (CT, n = 34; FR, n = 41) (A), 
food (CT, n = 34; FR, n = 41) (B) and water (CT = 10; FR = 16) (C) intake in female rats before (baseline) and 
after maintenance on a CT (open circle) or FR (closed circle) diet. *p < 0.05 vs. CT, by two-way ANOVA and 
Bonferroni post-hoc test (time; diet). Values are expressed as the mean ± SEM.
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Basal MAP and HR and plasma volume were lower in the FR group (Table 1) as we previously found9,10 and 
as observed in self-imposed cases of FR in humans1,2. The hematocrit was higher in the FR compared to the CR 
group, which is also similar to what is found in individuals suffering from low food intake18. FR reduced urine 
volume by greater than 30% but had no effect on plasma ALDO or plasma potassium though plasma sodium 
showed a trend towards being elevated (Table 1). FR also caused reductions in sodium and potassium intake and 
excretion (UNaV, UKV) although net sodium (Na+ intake – UnaV) and potassium balance (K+ intake - UKV) were 
maintained (Table 1). Under lengthier or more severe FR conditions, sodium and potassium balance can become 
impaired3, however, in our experimental conditions, we found FR for 14 days did not impair sodium or potassium 
balance. Thus, this protocol represents a moderate model of metabolic dysfunction.
Ang-[1–10], Ang-[1–8] and Ang-[1–7] pressor and HR responses. To study the impact of FR on 
RAS hemodynamic regulatory mechanisms, we measured BP and HR responses to Ang-[1–10]. FR increased 
the pressor (Fig. 2A,C) and reduced the HR (Fig. 2B,D) responses to Ang-[1–10] infusion. Pretreatment with the 
angiotensin converting enzyme (ACE) inhibitor, captopril prevented the pressor and HR responses to Ang-[1–10] 
in both the FR and CT groups. FR attenuated the pressor (Fig. 3A,C) and HR (Fig. 3B,D) responses to Ang-[1–8] 
infusion. FR altered the time course of MAP (Fig. 4A,C) and HR (Fig. 4B,D) responses to Ang-[1–7] infusion 
without affecting peak MAP and HR responses.
Plasma ACE, ACE2 and renin activity. The major catabolic enzymes of the RAS include renin, ACE and 
ACE2. Renin acts upon angiotensinogen to produce the inactive decapeptide Ang-[1–10]. ACE then catabolizes 
Ang-[1–10] to produce the vasoconstrictor Ang-[1–8]. ACE2 removes one amino acid Ang-[1–8] to form the 
vasodilator Ang-[1–7]. To assess the effects of FR on key metabolic pathways of the RAS, renin activity and ACE 
and ACE2 were determined in the plasma. The rate of product formation produced by ACE (Fig. 4A,D) and 
ACE2 (Fig. 5B,E) was faster in the plasma of FR compared to CT animals. In contrast, FR had no effect on plasma 
renin activity (Fig. 5C) and the ratio of plasma Ang-[1–10]/AGT (Fig. 5F).
Plasma AGT and Ang peptides. To further assess the effects of FR on the RAS metabolic pathway, angi-
otensin peptides were measured by the RAS fingerprint® method. FR increased plasma levels of AGT and Ang-
[1–8] (Table 2, Fig. 6). FR had no effect on basal plasma levels of Ang-[1–10], Ang-[2–10], Ang-[2–8], Ang-[3–8] 
and Ang-[1–5]. The other Ang peptides were below the limits of detection; however, after Ang-[1–10] infusion, 
AGT, Ang-[1–10], Ang-[1–8], Ang-[1–5], Ang-[2–10], Ang-[2–8], and Ang-[3–8] were increased to a greater 
extent in the FR compared to the CT group.
AT1R, AT2R, and MasR mRNA expression in mesenteric vessels. To determine the effect of FR on 
angiotensin receptors in a key RAS target tissue, we measured AT1R, AT2R and masR mRNA expression in mes-
enteric vessels. AT1R mRNA expression was 72% higher in the FR compared to CT group (Fig. 7A). In contrast, 
no differences between the FR and CT groups were observed in mRNA expression of the AT2R (Fig. 7B) or MasR 
(Fig. 6C).
CT FR
P value (<)Mean ± SEM, N Mean ± SEM, N
MAP (mmHg) 113 ± 1.9, n = 33 107 ± 1.6, n = 32 0.03‡
HR (bpm) 380 ± 5.8, n = 33 357 ± 8.9, n = 32 0.03‡
Plasma Aldosterone (pg/mL) 783 ± 123, n = 8 1020 ± 155, n = 7 0.2
Hematocrit (fraction) 0.45 ± 0.002, n = 7 0.48 ± 0.007, n = 6 0.001‡
Plasma volume (mL) 9.0 ± 1.0, n = 8 6.1 ± 0.7, n = 8 0.03‡
Urine volume (mL/24 h) 11.6 ± 0.7, n = 8 5.0 ± 0.3, n = 8 0.001‡
Na+ intake (mmol/24 h) 1.893 ± 0.087, n = 8 0.673 ± 0.002, n = 8 0.001‡
UNa (mmol/L) 165.7 ± 4.7, n = 8 141.6 ± 11.7, n = 8 0.09
UNaV (mmol/24 h) 1.92 ± 0.10, n = 8 0.70 ± 0.045, n = 8 0.001‡
Na+ intake - UNaV (mmol/24 h) −0.05 ± 0.05, n = 8 −0.05 ± 0.05, n = 8 0.99
Plasma Na+ concentration (mmol/L) 138.7 ± 0.9, n = 8 142.3 ± 1.4, n = 8 0.056
K+ intake (mmol/24 h) 4.033 ± 0.18549, n = 8 1.430 ± 0.0051, n = 8 0.001‡
UK (mmol/24 h) 361 ± 1130, n = 8 321 ± 1232, n = 8 0.04‡
UKV (mmol/24 h) 4.15 ± 0.164, n = 8 1.59 ± 0.051, n = 8 0.001‡
K+ intake - UKV (mmol/24 h) −0.19 ± 0.113, n = 8 −0.22 ± 0.051, n = 8 0.8
Plasma K+ concentration (mmol/L) 5.3 ± 0.26, n = 8 4.9 ± 0.13, n = 8 0.3
Urine protein (mg/mL) 10.7 ± 0.41, n = 8 11.8 ± 0.71, n = 7 0.2
Table 1. Effect of FR on hemodynamic and urine and plasma parameters. Basal physiological values in female 
rats subjected to control (CT) or food restricted (FR) diet for 14 days. ‡P < 0.05 vs CT, by unpaired Student’s 
t-test. BW, body weight; MAP, mean arterial pressure; HR, heart rate; UNaV, urinary excretion of Na+; UKV, 
urinary excretion of K+.
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Figure 2. Effect of FR on MAP and HR responses to infusion of Ang-[1–10]. Shown are the changes (A,B) 
or maximum changes from baseline (C,D) in MAP (A,C) and HR (B,D) after vehicle (Veh), Ang-[1–10] or 
captopril (Cap) infusion in CT (open circle) and FR (closed circle) female rats (n = 7/group). Basal MAP (mm 
Hg): CT, 106 ± 1.3 vs. FR, 104 ± 3.0. Basal HR (bpm): CT, 368 ± 13 vs. FR, 355 ± 14. *P < 0.05 vs. CT by two-
way ANOVA and Bonferroni post-hoc test (time; diet); #P < 0.001 vs. vehicle, same animal group by unpaired 
Student’s t-test and ‡p < 0.002 vs. CT, same treatment, by two-way ANOVA and Bonferroni post-hoc test (drug; 
diet). Values are expressed as the mean ± SEM.
Figure 3. Effect of FR on MAP and HR responses to infusion of Ang-[1–8]. Shown are the changes (A,B) 
or maximum change from baseline (C,D) in MAP (A,C) and HR (B,D) after vehicle or Ang-[1–8] infusion 
in CT (open circle) and FR (closed circle) female rats (n = 8/group). Basal MAP (mm Hg): CT, 117 ± 5.0 vs. 
FR, 114 ± 5.0; Basal HR (bpm): CT, 386 ± 14 vs. *FR, 309 ± 18. *P < 0.001 vs. CT by two-way ANOVA and 
Bonferroni post-hoc test (time; diet); #P < 0.01 vs. vehicle, same animal group by unpaired Student’s t-test and 
‡p < 0.001 vs. CT, same treatment, by two-way ANOVA and Bonferroni post-hoc test (drug; diet). Values are 
expressed as the mean ± SEM.
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AT1R antagonist responses. To investigate the effect of FR on AT1R activity, we measured depressor 
responses to the AT1R antagonist, losartan. We found that the magnitude of the BP lowering effect of losartan 
was greater in the FR compared to CT group (Fig. 8A,C). FR had no effect on the HR responses to losartan 
(Fig. 8B,D).
α1-adrenergic receptor agonist responses. To determine if FR selectively altered pressor responses 
mediated by the RAS, we studied the effect of FR on pressor responses to the α1-adrenergic receptor agonist 
L-phenylephrine. We found that FR had no effects on the pressor response to L-phenylephrine (Fig. 9A,C); 
however, L-phenylephrine caused was a greater reduction in HR in the FR compared to CT group (P < 0.0001) 
(Fig. 9B,D).
Discussion
A major finding of this study is that severe FR increased plasma Ang-[1–8] under conditions in which the ani-
mals remained hypotensive. Plasma Ang-[1–8] was increased primarily due to an increase in the conversion of 
AGT to Ang-[1–8] as a result of increased ACE activity and not renin. FR had no effect on plasma Ang-[1–10] 
or plasma renin activity even though AGT levels were higher in the FR compared to CT animals. While renin 
is well known to regulate plasma Ang-[1–8] through conversion of AGT to Ang-[1–10] and subsequent activa-
tion of ACE, previous studies in rat liver showed plasma Ang-[1–8] could also be regulated independently of 
renin directly through ACE19. Furthermore, studies have shown that AGT can also be degraded to Ang-[1–8] in 
renin-independent ways20–23. These findings indicate severe FR activates the RAS in a renin-independent manner.
A reduction in plasma volume is a well-known stimulus for Ang-[1–8] production24. When plasma volume is 
reduced by hemorrhage, Ang-[1–8] rises in the plasma causing increased vasoconstriction and water and sodium 
retention25. This activation of the RAS is a survival response, designed to counteract the drop in BP. Severe FR is 
likely to trigger this same mechanism since plasma volume is markedly reduced on the FR diet; however, even 
though the RAS is activated, the animal is unable to attain normal blood pressure due to the large drop in blood 
volume.
After infusion of Ang-[1–10], plasma AGT was reduced in the CT group. These findings support previous 
studies showing plasma AGT is reciprocally regulated by changes in plasma Ang-[1–8]26,27. In contrast, plasma 
AGT was up-regulated in the FR group after Ang-[1–10] infusion. Thus, the normal negative feedback response 
to the increase in plasma levels of Ang-[1–8] is either suspended or masked as a result of the need to compensate 
for the decrease in plasma volume.
Another major finding was that FR caused a coordinate up-regulation in both ACE and ACE2 activity. Many 
studies have shown ACE and ACE2 are regulated in a ying-yang manner. For example, ACE mRNA & protein 
expression was increased while ACE2 mRNA & protein expression was reduced in the paraventricular nucleus 
Figure 4. Effect of FR on MAP and HR responses to infusion of Ang-[1–7]. Shown are the changes (A,B) or 
maximum change from baseline (C,D) in MAP (A,C) and HR (B,D) after vehicle or Ang-[1–7] infusion in CT 
(open circle; n = 10) and FR (closed circle; n = 9) female rats. Basal MAP (mm Hg): CT, 106 ± 1 vs. FR, 104 ± 3. 
Basal HR (bpm): CT, 380 ± 7 vs. FR, 358 ± 12. *P < 0.05 vs. CT by two-way ANOVA and Bonferroni post-hoc 
test (time; diet). Values are expressed as the mean ± SEM.
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of the hypothalamus of the spontaneously hypertensive rat when compared to Wistar Kyoto normotensive con-
trols28. However, other studies have found ACE and ACE2 can act coordinately. The mRNA & protein expres-
sion of both ACE and ACE2 were reduced by diabetic nephropathy in kidney tubules29. Although FR caused a 
Figure 5. Effect of FR on plasma ACE, ACE2 and renin activity. Shown is the time course of product formation 
(A,B) and enzyme activity (C,D,E) for ACE (n = 8/group) (A,D), ACE2 (CT, n = 8; FR = 9) (B,E) and renin (CT, 
n = 8; FR, n = 10) (C) in the plasma and the ratio of Ang-[1–10] over AGT production (CT, n = 10; FR, n = 11) 
(F) in CT (grey circle; white bar) and FR (closed circle; black bar) female rats. *P < 0.001 vs. CT by two-way 
ANOVA and Bonferroni post-hoc test (time; diet); ‡P < 0.0001 vs. CT, same treatment, by unpaired Student’s t-
test. Values are expressed as the mean ± SEM.
Peptide








mL±SEM) P value CT P value FR P value
AGT (ng/mL) 2086 ± 72 2492 ± 24 <0.001‡ 1810 ± 65 2656 ± 70 <0.001‡ 0.01# 0.04#
Ang-[1–10] 20.1 ± 1.3 20.8 ± 2.7 0.99 70.2 ± 9.5 102 ± 8.7 <0.005‡ <0.001# <0.001#
Ang-[2–10] 5.9 ± 0.6 5.0 ± 0.5 0.96 8.4 ± 0.8 16 ± 2.1 <0.001‡ <0.02 <0.001#
Ang-[1–9] <1.7 ± 0.04 <1.6 ± 0.05 nd <1.5 ± 0.1 <1.4 ± 0.03 nd nd nd
Ang-[1–8] 50.7 ± 4.9 64.6 ± 3.5 <0.05‡ 67.9 ± 7.1 107 ± 16 <0.05‡ 0.055 <0.01#
Ang-[1–7] <2.2 ± 0.04 <2.1 ± 0.05 nd <1.6 ± 0.03 <1.6 ± 0.04 nd nd nd
Ang-[2–8] 11.1 ± 1.2 11.5 ± 1.3 0.99 8.9 ± 1 16.0 ± 2 <0.02‡ 0.26 0.12
Ang-[3–8] 3.7 ± 0.5 4.5 ± 0.3 0.42 3.8 ± 0.3 6.1 ± 0.6 <0.005‡ 0.90 <0.05#
Ang-[2–7] <2.3 ± 0.2 <1.9 ± 0.2 nd <1.2 ± 0.04 <1.1 ± 0.04 nd nd nd
Ang-[3–7] <1.2 ± 0.02 <1.2 ± 0.02 nd <1.2 ± 0.04 <1.1 ± 0.03 nd nd nd
Ang-[1–5] 2.3 ± 0.2 2.0 ± 0.2 0.88 3.1 ± 0.1 4.8 ± 0.6 <0.01‡ <0.02# <0.001#
Table 2. Effect of food restriction on plasma angiotensin peptides before and after Ang-[1–10] infusion. Blood 
angiotensinogen (n = 8/group) and angiotensin (Ang) peptide concentrations before (CT, n = 10; FR, n = 11/
group) and after Ang-[1–10] infusion (n = 8/group) in female rats subjected to control (CT) or food restricted 
(FR) diet for 14 days. ‡P < 0.05 vs CT by two-way ANOVA and Bonferroni post-hoc test (drug; diet); #P < 0.05 
vs vehicle, same group, by unpaired Student’s t-test. (<) in front of a number indicates below threshold of 
signal-to-noise; nd, not detectable.
www.nature.com/scientificreports/
7SCientifiC RePoRtS |  (2018) 8:10327  | DOI:10.1038/s41598-018-28593-6
coordinate up-regulation of activity of both the enzyme that produces Ang-[1–8] (i.e., ACE) and the enzyme that 
degrades Ang-[1–8] (i.e., ACE2), ACE is the predominant RAS catabolic pathway activated by the FR diet since 
plasma Ang-[1–7] was below the assay detection limit.
Figure 6. Depiction of the relative effect of FR on plasma angiotensin (Ang) peptides. Shown is the RAS 
fingerprint of Ang peptides in CT (n = 10) (A,C) and FR (n = 11) (B,D) female rats before (A,B) and after Ang-
[1–10] infusion (C,D) (n = 8/group). The numbers in parentheses refer to the specific Ang peptide with the 
peptide concentration (pg/mL) listed below each peptide. For example, (1–10) represents Ang-[1–10]. Red and 
green circles reflect biologically active and inactive Ang peptides, respectively. The relative amounts of plasma 
peptides are depicted by the circle volumes, which are drawn to a relative scale.
www.nature.com/scientificreports/
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Few studies to date have investigated the effects of caloric or protein restriction on ACE and ACE2 activity; 
however, one study in ewes showed that restricting caloric intake by 30% in the periconceptional period increased 
the abundance of ACE protein and mRNA30. In contrast, individuals with AN were reported to have lower plasma 
ACE activity than age-matched controls31, however, the calorimetric method used to measure ACE in this human 
study has substrate specificity limitations that could impact the interpretation of the data. Therefore, it is not 
known whether the discrepancy between the human and animal data (rats and ewes) is due to species differences 
in the effects of FR on ACE or to methodological differences in assaying ACE activity.
Further evidence that the severe FR diet causes increased synthesis of plasma Ang-[1–8] is shown in the Ang-
[1–10] infusion experiments. Ang-[1–10] caused a greater pressor response in the FR animals than CT group 
(Fig. 2). Ang-[1–10] can elicit a pressor response through its conversion to Ang-[1–8] by ACE. In fact, Ang-[1–
10] infusion increased plasma Ang-[1–8] to a greater extent in the FR group (1.6-fold) than CT animals (1.3-fold) 
(Table 2). Not only was Ang-[1–8] up-regulated, Ang-[1–10] infusion led to higher plasma levels of Ang-[1–10] 
(5-fold) vs CT (3.5-fold) even though no differences in basal Ang-[1–10] were observed. The higher levels of 
plasma Ang-[1–10] in the FR group could be due to less catabolism or sequestration of plasma Ang-[1–10] than 
in the CT animals or to more Ang-[1–10] synthesis from endogenous AGT. In this regard, there was 20% more 
AGT under basal conditions in the FR group compared to CT animals (Table 2).
Alternatively, the decapeptide can cause a pressor response by conversion to another pressor peptide, Ang-
[2–8], through the actions of aminopeptidase A and ACE independently of Ang-[1–8] formation32. We found that 
infusion of Ang-[1–10] in FR animals increased production of Ang-[2–8] by 1.4-fold, whereas no such increase 
in Ang-[2–8] was observed in the CT animals. These findings indicate that FR increased the activity of Ang-[1–8] 
metabolic pathways through ACE and possibly aminopeptidase A.
Ang-[1–8] mediates its physiological actions by binding to its receptors in target tissues including the vascu-
lature. In the present study, we found that the FR diet up-regulated mRNA expression of the AT1R. Our findings 
Figure 7. Effect of FR on AT1R, AT2R and MasR mRNA in mesenteric vessels. Shown is the basal mRNA 
expression levels of the AT1R (A), AT2R (B) and MasR (C) in mesenteric vessels from CT (white bar; n = 8) 
and FR (black bar; n = 9) female rats. ‡P < 0.01 vs. CT by unpaired Student’s t-test. Values are expressed as the 
mean ± SEM.
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Figure 8. Effect of FR on MAP and HR responses to infusion of losartan. Shown are the changes (A,B) and 
maximum change from baseline (C,D) in MAP (A,C) and HR (B,D) after vehicle or losartan (Los) treatment 
in CT (open circle; white bar; n = 9) and FR (closed circle; black bar; n = 10) female rats. Basal MAP (mm 
Hg): CT, 122 ± 2 vs. *FR, 108 ± 1. Basal HR (bpm): CT, 374 ± 18 vs. FR, 365 ± 13. *P < 0.0001 vs. CT by two-
way ANOVA and Bonferroni post-hoc test (time; diet); #P < 0.05 vs. vehicle, same animal group by unpaired 
Student’s t-test and ‡p < 0.001 vs. CT, same treatment, by two-way ANOVA and Bonferroni post-hoc test (drug; 
diet); Values are expressed as the mean ± SEM.
Figure 9. Effect of FR on MAP and HR responses to infusion of phenylephrine (PHE), an α-1 adrenergic 
receptor agonist. Shown are the changes (A,B) or maximum change from baseline (C,D) in MAP (A,C) and HR 
(B,D) after L-phenylephrine (299 nM/mL, infusion velocity: 2.2 mL/h) in CT (open circle) or FR (closed circle) 
rats (n = 9/group). Basal MAP (mm Hg): CT, 116 ± 3 vs. *FR, 106 ± 3. Basal HR (bpm): CT, 372 ± 15 vs. FR, 
396 ± 14. *P < 0.001 vs. CT by two-way ANOVA and Bonferroni post-hoc test (time; diet); ‡P < 0.05 vs. CT, by 
unpaired Student’s t-test; Values are expressed as the mean ± SEM.
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are supported by a study showing that a protein restricted diet increased AT1R protein in rat aorta vessels15. This 
up-regulation of AT1R expression could be a compensatory response to the BP reduction induced by FR by serv-
ing to increase vasoconstriction in resistance vessels. This idea is supported by the AT1R antagonist infusion stud-
ies since we found losartan lowered BP to a greater extent in the FR animals compared to the CT group indicating 
that the activity of AT1Rs is greater in the FR rats. These results support a previous report showing that losartan 
caused a greater reduction in MAP in rats maintained on a low protein diet compared to controls15.
Given that the FR diet had no effect on AT2R or masR mRNA expression, it is unlikely that these receptors play 
a major role in the hypotension and bradycardia observed in this model. Only a few reports have investigated the 
effect of food or nutrient deficiency on AT2R expression and no studies to date have reported effects on the masR. 
One study in pregnant ewes fed a 50% nutrient-restricted diet during gestation found that the offspring were 
hypertensive and expressed high AT2R mRNA expression in the renal medulla33, however, the effect of nutrient 
restriction on AT2R expression in the mother was not investigated. Thus, it is not known whether the lack of effect 
of a FR diet on AT2R mRNA expression in mesenteric vessels is specific to rodents, target tissue differences (mes-
enteric vessels vs. renal medulla), the nature of the diet or other experimental differences.
The paradoxical effect of hypotension in the presence of increased plasma Ang-[1–8] and mesenteric AT1R 
expression is likely due to the inability of Ang-[1–8]-mediated vasoconstrictor mechanisms to overcome the 
reduction in MAP induced by low plasma volume. This idea is supported by the Ang-[1–8] infusion studies, 
which found Ang-[1–8] caused smaller increases in MAP in FR compared to CT animals (Fig. 3). The fact that 
basal plasma Ang II and mesenteric AT1R expression are both higher in FR rats than CTs raises the possibility that 
the AT1R is dysfunction and unable to cause sufficient vasoconstriction to raise BP.
Similar observations were seen in a study of patients with AN compared to age-matched controls; patients 
with AN had to be infused with a higher concentration of Ang-[1–8] to achieve a 20 mmHg increase in BP17. 
Furthermore, in a mouse model of hypotension induced by severe intravascular volume depletion and decreased 
renal Na+ reabsorption, aortic vessels exhibited decreased contractile reactivity34. This study suggested the cause 
of the reduced vasoconstriction was the reduced vascular hypertrophy.
An alternative interpretation of our findings is that the attenuated pressor response to Ang-[1–8] in the FR 
group is due to a ceiling effect on the ability of the vessel to vasoconstrict; however, this possibility would be 
AT1R specific since the vasoconstrictor, L-phenylephrine, increased MAP to a similar extent in the FR and CT 
animals. The normal BP response to Ang-[1–8] infusion is four-fold higher than to an equivalent dose of Ang-[1–
10]35,36, which is similar to our findings in the control animals. In contrast, we found no differences in the pressor 
response in the FR animals between Ang-[1–10] and Ang-[1–8]. This attenuated pressor response to Ang-[1–8] 
may be due to impaired AT1R signaling even though AT1R mRNA expression in the FR animals was increased 
2-fold in the mesenteric vessels. We were not able to measure AT1R protein expression because of the lack of AT1R 
antibody specificity nor could we detect AT1Rs by radioligand binding in mesenteric vessels. Thus, the caveat 
remains that the observed increased in AT1R mRNA expression may not reflect increased AT1R protein.
Another explanation for the lower Ang-[1–8] responsiveness in the FR group could be receptor desensitiza-
tion. In a mouse model of sepsis, the animals developed hypotension and at the same time, the sensitivity of the 
kidney vasculature to Ang-[1–8] was reduced as a result of AT1R desensitization37. Another contributing factor 
could be nitric oxide since FR reduces plasma nitric oxide9 and lowering nitric oxide is associated with endothelial 
dysfunction. Moreover, increases in plasma Ang-[1–8] and AT1R expression are known to lower nitric oxide38,39.
Albumin plays a key role in controlling plasma osmolality besides plasma volume. Low plasma protein or 
sodium concentration will result in hypoosmolality causing water inside vessels to move into the intercellular 
space, resulting in edema and low blood volume40. Changes in blood osmolality and blood volume are well known 
to stimulate the vasoconstrictor arm of the RAS41. We previously showed that this FR model causes hypoalbu-
minemia9,42. Taken together, these studies suggest hypoalbuminemia contributes to both the hypotension and 
activation of the vasoconstrictor arm of the RAS in individuals experiencing inadequate levels of dietary protein 
as a result of AN, famine or other reasons18.
It is well known that the RAS can regulate the kidney function and BP. Another possible reason for the low 
BP in FR is due to the inability of the kidney to respond to the high circulating Ang-[1–8] levels. In animals with 
low plasma volume and intact RAS, Ang-[1–8] stimulates ALDO production and renal sodium and water reab-
sorption43. However, the FR rats in this study did not respond to the elevated Ang-[1–8] as evidenced by their 
net sodium balance (Table 2) and ALDO levels (Table 1). This indicates that kidneys of FR animals have become 
refractory to the actions of Ang-[1–8], the sum total of which results in reduced plasma volume and BP. One likely 
mechanism is desensitization of the AT1R, as it has been previously shown that mice with hypotension undergo 
renal AT1R desensitization37. Another result that can corroborate the possible AT1R desensitization is the nor-
mal basal plasma levels of ALDO in FR. It is well documented that Ang-[1–8] can act in the adrenal AT1R and 
release ALDO, which did not happened in FR rats. Another explanation for the lack of effect on plasma ALDO 
concentrations is a possible ceiling effect of calcium influx, which is necessary for the Ang-[1–8] ALDO release 
signaling44. Future studies will be needed to understand the mechanism on desensitization to Ang-[1–8] in FR.
The heptapeptide Ang-[1–7] has been shown to have vasodilator effects45; however, infusion of the peptide had no 
effect on MAP in the CT rats and only a small pressor effect was observed in the FR rats. Moreover, plasma levels of 
Ang-[1–7] after vehicle or Ang-[1–10] infusion were not detectable using the highly sensitive RAS-Fingerprint tech-
nique. These results suggest Ang-[1–7] is not a major contributor to BP homeostasis in this FR animal model.
As in patients with AN, HR was slower in the FR compared to CT animals. Bradycardia could be due to high 
parasympathetic output to the heart. Increased parasympathetic activation could explain the higher HR response 
after L-phenylephrine infusion in FR compared to CT animals due a change in the baroreflex. Furthermore, the 
HR response to Ang-[1–10] infusion was attenuated in the FR group. It is well known that in response to an acute 
increase in BP, HR is decreased by baroreflex stimulation in an attempt to bring BP back to normal46. Therefore, the 
Ang-[1–10]-induced increase in BP likely stimulates the baroreflex resulting in a compensatory decrease in HR.
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In conclusion, FR reduces plasma volume and BP. In order to maintain peripheral blood perfusion, the pres-
sor arm of the RAS is activated increasing AGT and Ang-[1–8] levels, ACE activity and AT1R responsiveness. 
However, the RAS upregulation is inadequate to achieve full BP homeostasis. RAS activation is limited by attenu-
ated Ang-[1–8] pressor responses, negative feedback to AGT and impaired ALDO responsiveness. Furthermore, 
once the period of severe FR ends, it is not clear if the RAS remains activated. If so, this up-regulation of the RAS 
may contribute to the long term adverse cardiovascular consequences observed in individuals who currently 
have or previously suffered from FR either voluntarily or not. Thus, it will be important to further investigate the 
mechanisms by which FR resets the RAS and the long term adverse consequences to the cardiovascular system.
Methods
Ethical Approval. All procedures conducted in Brazil were approved by the Ethics Committee for Animal 
Research (CEUA-UFOP; no. - 2016/02) of the Universidade Federal de Ouro Preto. The Georgetown University 
Animal Care and Use Committee approved all protocols conducted in the USA (no. 16:1234). All experimental 
protocols and animal maintenance was performed in accordance with the NIH Guide for the Care and Use of 
Laboratory Animals, European Convention for the Protection of Vertebrate Animals used for Experimental and 
other Scientific Purposes and according to the journal policies and regulations on animal experimentation. All 
efforts were made to follow the 3 Rs (Replacement, Reduction and Refinement) and to avoid any unnecessary 
distress to the animals.
Animals. All experiments were conducted on female Fischer rats initially weighing 180–190 g at 3 months 
of age. Studies were conducted at both the Federal University of Ouro Preto (UFOP, Brazil) and Georgetown 
University (GU, USA). In Brazil, animals were bred in the University Center of Animal Sciences, UFOP. In the 
USA, animals were purchased from Envigo Corp. (Frederick, MD). All animals were housed in individual cages 
on a 12 hr light-dark cycle at room temperature (24 °C). The same person (AS) conducted the studies at UFOP and 
at GU. All of the experiments involving BP measurements were done at UFOP and all the samples processed for 
biochemical and molecular analysis were done at GU. For all studies conducted at GU, we confirmed that the FR 
diet had similar effects on BW, food and water intake, tissue weight, the estrous cycle, BP, and HR as we observed 
at UFOP. We chose to focus on a female model of severe food restriction because there are more women than men 
who experience periods of severe food restriction due to self-imposed diets and eating disorders3. Furthermore, 
while many studies have investigated the effects of malnutrition during pregnancy on the offspring4,5 few have 
focused on the adverse consequences of severe FR to the mother prior to pregnancy.
Diet. After receiving the animals, they stayed in the animal facility for 2 weeks to recover from potential travel 
stress and to enable acclimatization to the environment. After 2 weeks, the animals were single housed and food 
intake and BW were determined daily at 5:00 pm for each animal for two weeks. After this period, the animals 
were randomly divided into two groups: control (CT) or food-restricted (FR). The average food consumption 
determined for individual animals during the previous 2 weeks was used to calculate the amount of food given 
to the FR group, which was 40% of the average of their normal consumption (determined two weeks prior to the 
beginning of the study). BW was measured daily before replenishing the food, as we previously described9. The 
CT group had free access to food for the duration of the study period. All animals received a standard rat diet 
(Rodent diet 20, #5053, LabDiet, Marlborough, MA) and had ad libitum access to water.
Catheter Implantation. After two weeks on CT or FR diets, the animals were subjected to catheter implan-
tation, as described previously47. In brief, rats were anaesthetized (2.5% isoflurane at 3 L/min O2) and polyethyl-
ene catheters were inserted into the femoral artery for cardiovascular measurements and into the femoral vein for 
drug infusions. The catheters were tunneled subcutaneously and exteriorized at the back of the neck. After sur-
gery, analgesics (4 mg/kg Ketoflex, 0.1 mL/300 g, s.c) and antibiotics (0.2 mL/100 g, penicillin, streptomycin, dihy-
drostreptomycin, s.c.) were administered post-surgery and 24 hrs after surgery if any sign of pain was observed. 
While the catheter inserted into the femoral artery could reduce blood flow to the lower leg, the rats quickly shift 
flow to collateral vessels to compensate for the loss of blood flow from the femoral artery and they recover well 
with minimum distress using this widely used method9,10. Experimental procedures began 48 h after recovery 
from the anesthesia. Separate animals were used for drug infusion and molecular studies, except the group that 
received Ang-[1–10] infusions since blood was collected from these animals to measure Ang peptides.
MAP & HR. All experiments recording MAP and HR were made in conscious freely moving rats. The rat 
arterial catheter was connected to a pressure transducer (MLT0699; ADI Instruments, Bella Vista, Australia) 
and a signal amplifier (ETH-400; CB Sciences Inc., Milford, MA, USA). The analog signal from the amplifier 
was digitized by a 12-bit analog-to-digital converter (PowerLab/400; ADI Instruments), and the pulsatile arterial 
pressure was recorded at 1000 Hz using Chart 7.0 for Windows software (ADI Instruments). MAP and HR were 
derived on-line from the pulsatile arterial pressure measurements using pulse-to-pulse analysis15. Data for HR 
and MAP values were recorded continuously. Baseline MAP and HR were determined during the two min-period 
that preceded drug injections and are expressed as the mean ± SEM. Responses to treatments are calculated from 
continual 2 min averages after drug infusions and are expressed as the change in MAP or HR from baseline.
Experimental design. Before the experiments were performed, the animals were brought to the experimen-
tal room in which the temperature was maintained at 24–25 °C. The animals stayed in their home cages for 2 h 
before the protocol started. All the following experiments were performed during the light cycle. The experiment 
commenced only after HR and MAP were stabilized for at least 10 min. All the acute infusions were made using a 
0.5 mL Hamilton syringe (Hamilton Robotics, Reno, NV). The first experiment evaluated the influence of FR on 
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Ang-[1–10] and ACE BP responses. Both CT and FR rats received an intravenous (i.v.) bolus infusion of vehicle 
(0.1 mL/100 g of BW). After 10 min, they were infused with Ang-[1–10] (154 nmol/L − 0.1 mL/100 g of BW) fol-
lowed by recording the MAP and HR for 30 min. Captopril was infused on the second day via bolus intravenous 
injection (9.2 mmol/L − 0.1 mL/100 g of BW) instead of vehicle, followed by Ang-[1–10]. The first drug infused 
was randomized. The second series of experiments evaluated the influence of FR on Ang-[1–8] and losartan on 
MAP and HR responses. On the first day, vehicle or Ang-[1–8] (191 nmol/L − 0.1 mL/100 g of BW) was infused. 
One day later, vehicle or losartan (24 mmol/L − 0.1 mL/100 g of BW) was infused and cardiovascular responses 
were recorded for 30 min after each infusion or until baseline levels were reached. The third group of experiments 
evaluated the effects of FR on MAP and HR responses to Ang-[1–7]. In those experiments, the rats received 
vehicle or Ang-[1–7] (191 nmol/L − 0.1 mL/100 g of BW) by i.v. infusion in bolus followed by recording the cardi-
ovascular responses for 40 min. The last experiment tested the BP amplitude responses to a non-angiotensin sys-
tem agonist, i.e., the α1-adrenergegic receptor agonist, phenylephrine (299 nM/mL, infusion velocity: 2.2 mL/h). 
MAP and HR responses were recorded until they returned to baseline.
Plasma Sodium and Potassium Concentration and Balance. This experimental group was acclimated 
to the metabolic cage for 48 hours beginning on day 11. On day 13, 24 h collections began. Rats were given ad 
libitum access to water and the amount of powdered rat chow (Rodent diet 20, #5053, LabDiet, Marlborough, MA 
- sodium 0.3% and potassium 1.10%) was given according to the diet protocol (see above), either ad libitum for 
CT rats (n = 7) or 40% of the CT diet for FR rats (n = 7). Food intake and urine volume were measured gravimet-
rically. At the end of the experiment, the animals were anaesthetized with isoflurane (2.5% isoflurane at 3 L/min 
O2) and the femoral artery and vein were catheterized for plasma volume measurements (see below). Blood was 
collected by abdominal aorta puncture and samples were centrifuged at 13,000 × g for 10 min to separate the 
plasma, which was stored in sterilized tubes at −80 °C until analysis. Sodium and potassium concentrations were 
determined by flame photometry (Model #2655-10; Cole-Parmer, Vernon Hills, IL).
Plasma Volume. Plasma volume was measured by the Evan’s blue dye technique as previously described48. 
In brief, after baseline blood collection, Evan’s blue dye (0.3 mg/ml) was infused into the venous catheter. Blood 
collections (0.2 mL), were taken from the arterial catheter at 5 and 10 min post-infusion. Plasma was collected fol-
lowing centrifugation of whole blood. Standards were made in 1% plasma at 0, 1, 5, 10, and 20 g/ml of Evan’s blue 
dye. The concentration of Evan’s blue dye was measured in a 100 μL plasma sample using a plate reader (FLUOstar 
Omega, BMG Labtech Inc., Cary, NC) at 610 nm at baseline before dye administration and at 5- and 10-min 
following dye administration. Background corrections were made by subtracting the observed concentration at 
baseline from the observed concentrations of the 5- and 10-min time points. Average plasma volumes were calcu-
lated by dividing the amount of administered Evan’s blue dye (75 g) by the background corrected concentrations.
Plasma AGT. Parallel animal groups were used for all plasma and urine measurements except plasma vol-
ume and angiotensin peptide concentrations. Plasma concentrations of AGT were measured using an ELISA 
kit (Immuno-Biological Laboratories, Minneapolis, MS)49. In brief, 100 μl/well of standard rodent AGT (0.08–
5.0 ng/mL) or plasma samples (1: 2,500 diluted in ELISA buffer) were added to the ELISA plate and incubated at 
37 °C for 1 h. After the incubation, the plates were rinsed seven times with Washing Buffer provided by the kit. 
The plates were then incubated with 100 μl/well of horseradish peroxidase-labeled C-terminal antibody (1:30 
diluted in antibody solution) at 37 °C for 30 min. After the incubation, the plates were rinsed nine times with 
Washing Buffer. Next, the plates were incubated with 100 μl/well of 3,3′,5,5′-tetramethylbenzidine solution under 
light-protected conditions at room temperature for 30 min. Finally, 100 μl of sulfuric acid (0.5 mol/l) was added to 
each well to stop the reaction. The absorbance values were measured at 450 nm.
Plasma ALDO. Plasma ALDO was measured by ELISA (Enzo Life Sciences, NY). 100 μL of plasma diluted 
1:5 was added to the plate immediately after the addition of antibody (50 μL) and the samples, the plate was incu-
bated overnight at 4 °C. The next day, the plate was washed 3 times and 200 μL of substrate was added followed by 
a 1 h incubation at room temperature. The reaction was stopped by the addition of trisodium phosphate solution. 
The absorbance values were measured at 405 nm.
RAS-Fingerprint®. After 14 days on the CT or FR diet, the rats were anesthetized with Inactin (80 mg/Kg) 
and infused (iv) with vehicle (0.2 mL) or Ang-[1–10] (154 nmol/L, 0.2 mL). After 10 min, whole blood was 
collected by cardiac puncture using a syringe filled with heparin and a proprietary protease inhibitor cocktail 
from Attoquant Diagnostics (Vienna, Austria). Plasma was obtained by centrifugation (2000 × g, 4 °C, 10 min) 
and stored at −80 °C until use. Circulating angiotensin peptide concentrations were determined by mass spec-
trometry using plasma samples collected in the presence of an inhibitor cocktail containing broad spectrum 
inhibitors against aspartic proteases (pepstatin A), cysteine proteases (p-hydroxymercuribenzoic acid), met-
alloproteases (ethylenediaminetetraacetic acid, 1,10-phenanthroline), serine proteases (AEBSF) and specific 
inhibitors for renin and aminopeptidases A and N at a final concentration of 5% v/v (Attoquant Diagnostics) 
and which completely blocked angiotensin metabolism. Stabilized samples were further spiked with stable 
isotope-labeled internal standards for each angiotensin metabolite including Ang-[1–10], Ang-[1–9], Ang-[1–8], 
Ang-[1–7], Ang-[1–5], Ang-[2–10], Ang-[2–8], Ang-[2–7], Ang-[3–8], and Ang-[3–7] at a concentration of 
200 pg/ml. Following C18-based solid-phase-extraction, samples were subjected to LC-MS/MS analysis using a 
reversed-phase analytical column (Acquity UPLC® C18, Waters, Milford, MA) operating in line with a XEVO 
TQ-S triple quadrupole mass spectrometer (Waters) in multiple reaction monitoring mode. Internal standards 
were used to correct for peptide recovery of the sample preparation procedure for each angiotensin metabolite 
in each individual sample. Angiotensin peptide concentrations were calculated considering the corresponding 
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response factors determined in appropriate calibration curves in original sample matrix, on condition that inte-
grated signals exceeded a signal-to-noise ratio of 10.
ACE Activity. Plasma ACE activity was measured as previously described50 with a few adaptations using the 
fluorogenic substrate Abz-Phe-Arg-Lys(Dnp)-Pro-OH. Reactions were conducted in 96 well microtiter plates 
containing 80 μL of Reaction Buffer (1 mol/L NaCl, 0.5 mmol/L ZnCl2, 75 mmol/L Tris, pH 7.5) in the presence of 
vehicle or the ACE inhibitor, captopril (20 µmol/L). Total enzyme activity was measured in the presence of vehicle 
(Reaction Buffer). Non-ACE activity was defined as peptidase activity measured in the presence of captopril. 
Specific ACE activity was defined as ACE activity minus non-ACE activity. Immediately after adding 10 μL of 
fluorogenic substrate, 10 µL of plasma, diluted 10× times, was added to each well to reach a final concentration 
of 60 μmol/L substrate. Product formation was determined at 37 °C by following the fluorescence as a function 
of time using a fluorescence plate reader (FLUOstar Omega) at an excitation wavelength of 320 nm and an emis-
sion wavelength of 410 nm. Initial velocities were determined from the rate of fluorescence increase over the 
10–60 min time course corresponding to the linear range of the assay. Enzyme kinetics were analyzed using Prism 
7.0 (GraphPad Software Inc, La Jolla, CA) (n = 8–9/group).
ACE2 Activity. Plasma ACE2 activity was measured as we described previously51 using the fluorogenic sub-
strate Mca-Ala-Pro-Lys(Dnp)-OH. Reactions were conducted in 96 well microtiter plates containing 85 μL of 
Reaction Buffer in the presence of vehicle or the ACE inhibitor, captopril (20 µmol/L) and the ACE2 inhibi-
tor MLN-4760 (20 µmol/L). Total enzyme activity was measured in the presence of vehicle (Reaction Buffer). 
Non-ACE activity was defined as peptidase activity measured in the presence of captopril (20 µmol/L). 
Nonspecific peptidase activity was defined as the enzyme activity measured in the presence of captopril and 
MLN-4760. Specific ACE2 activity was defined as non-ACE activity minus nonspecific peptidase activity. 
Immediately after adding 10 μL of fluorogenic substrate, 5 μL of plasma was added to each well to reach a final 
concentration of 30 μmol/L substrate. Product formation was determined at 37 °C by following the fluorescence 
as a function of time using a fluorescence plate reader (FLUOstar Omega) at an excitation wavelength of 320 nm 
and an emission wavelength of 410 nm. Initial velocities were determined from the rate of fluorescence increase 
over the 10–100 min time course corresponding to the linear range of the assay. Enzyme kinetics were determined 
using Prism software as described above (n = 8/group).
PRA. Plasma renin activity was measured using the 5-FAM/QXL®520 fluorescence resonance energy trans-
fer (FRET) peptide52. Reactions were conducted in 96 well microtiter plates containing 40 μL of plasma and the 
product formation was determined at 37 °C by following the fluorescence as a function of time using a fluores-
cence plate reader (FLUOstar Omega) at an excitation wavelength of 490 nm and an emission wavelength of 
520 nm. Data were recorded at 2 min intervals and initial velocities were determined from the rate of fluorescence 
increased over the 10–100 min time course, which corresponded to the linear range of the assay. The data were 
expressed as the rate of change in fluorescence, using the product of 5-carboxyfluorescein (5-FAM) as a marker 
for PRA (n = 10–8/group).
qPCR. The mesenteric cascade, including the superior mesenteric artery was dissected from the intestinal 
wall using ice cold phosphate buffered saline (PBS) and this tissue was removed from the same rat used for 
plasma measurements. After the fat and veins were removed from the vessels using an Olympus dissecting micro-
scope, the tissue was snap frozen in a dry ice-methanol bath and stored at −80 °C until use. The mesenteric ves-
sels were homogenized using ceramic microbeads and total RNA was extracted using RNeasy according to the 
manufacturer’s instructions (Bio-Rad). Purified RNA (1 μg) was reverse transcribed with a high-capacity cDNA 
reverse transcription kit. Quantitation of specific rRNA was performed by real-time PCR using the ABI Prism 
7700 Sequence Detection System (Applied Biosystems, Foster City, CA). The PCR reaction mixture consisted of 
RNase-free water, SYBR green supermix and 300 nmol/L specific primers as previously described53: angioten-
sin type 1a receptor (AT1aR) - F: 5′-CTC AAG CCT GTC TAC GAA AAT GAG-3′; R: 5′-TAG ATC CTG AGG 
CAG GGT GAA T-3′; angiotensin type 2 receptor (AT2R) - F: 5′-ACC TTT TGA ACA TGG TGC TTT G-3′; R: 
5′-GTT TCT CTG GGT CTG TTT GCT C-3′; MAS oncogene (Mas) - F: 5′-CACTGGCCCTCCTGATGAA-3′; 
R 5′-GGATGCCAGAATTGAACACAGA-3′; and, beta-actin - F: 5′-CCCATCTATGAGGGTTACGC-3′, R – 
5′-TTTAATGTCACGCACGATTTC-3′. The tissue levels of these cDNAs were calculated based on the standard 
curves.
Reagents. Ang-[1–10], Ang-[1–8], Ang-[1–7], captopril (Cap), losartan, inactin, L-phenylephrine and 
Evans blue dye were purchased from Sigma (St. Louis, MO). Isoflurane was purchased from Cristália Ltda 
(Itapira, SP, Brazil). Ketoprofen (Ketoflex) was purchased from Mundo Animal (Pindamonhangaba, SP, 
Brazil). Penicillin, streptomycin, and dihydrostreptomycin were purchased from Fort Dodge Animal Health 
(Hialeah, FL, USA). Abz-Phe-Arg-Lys(Dnp)-Pro-OH was purchased from GenScript (Piscataway, NJ, USA). 
Mca-Ala-Pro-Lys(Dnp)-OH was purchased from Enzo Life Science (Farmingdale, NY, USA). MLN-4760 
was purchased from EMD Milllipore (Billerica, MA, USA). Ceramic microbeads were purchased from MP 
Biomedicals (Solon, OH, USA). RNeasy was purchased from Qiagen (Germantown, MD, USA). RNase-free 
water, SYBR green supermix, and high-capacity cDNA reverse transcription kits (#1708890) were purchased 
from Bio-Rad (Hercules, CA, USA). Renin activity 520 Rat Renin Fluorimetric assay kit was purchased from 
SensoLyte (AnaSpec, San Jose-CA). Angiotensinogen Elisa kit was purchased from IBL (Hamburg, Germany). 
Aldosterone Elisa kit was purchased from Enzo Life Science (Farmingdale, NY, USA).
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Statistical Analysis. Prism 7.0 (GraphPad Software, La Jolla, CA, USA) was used to analyze all data and 
to construct the graphs. The data are expressed as mean ± standard error of the mean (SEM). The data for basal 
parameters characterization, enzyme activity, mRNA expression and peptide concentrations were analyzed first 
for normality using the Shapiro-Wilk normality test and when following the normality, were analyzed using the 
Student’s unpaired t-test to assess differences between groups. All the results expressed as a curve after drug stim-
ulation over time were compared by two-way (time and diet as factors) analysis of variance (ANOVA) followed 
by Bonferroni post-test using all the time-points showed in the graph. To test treatment effects within the same 
group, the Student’s t-test was used when the data followed a normal distribution. The significance threshold level 
was set at 0.05.
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